20:03 , May 5, 2017 |  BC Week In Review  |  Financial News

BioLight withdraws follow-on

On May 4, ophthalmology company BioLight Life Sciences Ltd. (Tel Aviv:BOLT) withdrew a follow-on seeking to list its shares on NASDAQ in a U.S. IPO underwritten by H.C. Wainwright and Feltl. In February 2016, the...
07:00 , Mar 14, 2016 |  BC Week In Review  |  Financial News

BioLight Life Sciences amends follow-on

BioLight Life Sciences Ltd. (Tel Aviv:BOLT), Tel Aviv, Israel   Business: Ophthalmic, Diagnostic   Date announced: 2016-03-09   Type: Follow-on   To be raised: Up to $10 million   Shares: 2.1 million   Price: TBD...
07:00 , Jul 14, 2014 |  BC Week In Review  |  Clinical News

Eye-D insert: Phase I/IIa started

Aerie Pharmaceuticals Inc . (NASDAQ:AERI), Bedminster, N.J.   Product: Eye-D insert   Business: Ophthalmic   Molecular target: NA   Description: Intraocular controlled-release insert containing latanoprost, a prostaglandin analog   Indication: Treat glaucoma   Endpoint: Safety...